Similar articles for PMID: 26515332

Year	Number of Results
2007	1
2008	1
2009	3
2010	2
2011	7
2012	5
2013	8
2014	11
2015	21
2016	16
2017	4
2018	1
2019	5
2020	5
2021	2
2022	3
2023	1
2024	0

1

KRAS polymorphisms are associated with survival of CRC in Chinese population.

Dai Q, Wei HL, Huang J, Zhou TJ, Chai L, Yang ZH. Dai Q, et al. Tumour Biol. 2016 Apr;37(4):4727-34. doi: 10.1007/s13277-015-4314-1. Epub 2015 Oct 29. Tumour Biol. 2016. PMID: 26515332

2

XRCC1 and ERCC1 polymorphisms are related to susceptibility and survival of colorectal cancer in the Chinese population.

Dai Q, Luo H, Li XP, Huang J, Zhou TJ, Yang ZH. Dai Q, et al. Mutagenesis. 2015 May;30(3):441-9. doi: 10.1093/mutage/geu088. Epub 2015 Feb 17. Mutagenesis. 2015. PMID: 25690281

3

MicroRNA-binding site polymorphisms in genes involved in colorectal cancer etiopathogenesis and their impact on disease prognosis.

Schneiderova M, Naccarati A, Pardini B, Rosa F, Gaetano CD, Jiraskova K, Opattova A, Levy M, Veskrna K, Veskrnova V, Buchler T, Landi S, Vodicka P, Vymetalkova V. Schneiderova M, et al. Mutagenesis. 2017 Oct 17;32(5):533-542. doi: 10.1093/mutage/gex026. Mutagenesis. 2017. PMID: 29048575

4

Association between rs61764370, rs9266, and rs140080026 polymorphisms of the KRAS gene and breast cancer risk in a Mexican population.

Gallegos-Arreola MP, García Verdín PM, Magaña-Torres MT, Figuera LE, Zúñiga-González GM, Rosales-Reynoso MA, Gómez-Meda BC, Puebla-Pérez AM. Gallegos-Arreola MP, et al. Eur Rev Med Pharmacol Sci. 2021 Nov;25(21):6454-6464. doi: 10.26355/eurrev_202111_27088. Eur Rev Med Pharmacol Sci. 2021. PMID: 34787849 Free article.

5

KRAS and VEGF gene 3'-UTR single nucleotide polymorphisms predicted susceptibility in colorectal cancer.

Yang M, Xiao X, Xing X, Li X, Xia T, Long H. Yang M, et al. PLoS One. 2017 Mar 22;12(3):e0174140. doi: 10.1371/journal.pone.0174140. eCollection 2017. PLoS One. 2017. PMID: 28328959 Free PMC article.

6

KRAS SNPs are related to colorectal cancer susceptibility and survival in Chinese people.

Liu X, Yang G, Huang J, Chai L, Liu X, Dai Q, Yang Z. Liu X, et al. Biomark Med. 2020 Jan;14(1):13-22. doi: 10.2217/bmm-2019-0172. Epub 2019 Nov 15. Biomark Med. 2020. PMID: 31729889

7

Association analysis of miRNA-related genetic polymorphisms in miR-143/145 and KRAS with colorectal cancer susceptibility and survival.

Wang D, Liu Q, Ren Y, Zhang Y, Wang X, Liu B. Wang D, et al. Biosci Rep. 2021 Apr 30;41(4):BSR20204136. doi: 10.1042/BSR20204136. Biosci Rep. 2021. PMID: 33825830 Free PMC article.

8

Comparison of the prevalence of KRAS-LCS6 polymorphism (rs61764370) within different tumour types (colorectal, breast, non-small cell lung cancer and brain tumours). A study of the Czech population.

Uvirova M, Simova J, Kubova B, Dvorackova N, Tomaskova H, Sedivcova M, Dite P. Uvirova M, et al. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2015 Sep;159(3):466-71. doi: 10.5507/bp.2015.029. Epub 2015 Jun 11. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2015. PMID: 26077004 Free article.

9

A let-7 KRAS rs712 polymorphism increases colorectal cancer risk.

Pan XM, Sun RF, Li ZH, Guo XM, Zhang Z, Qin HJ, Xu GH, Gao LB. Pan XM, et al. Tumour Biol. 2014 Jan;35(1):831-5. doi: 10.1007/s13277-013-1114-3. Epub 2013 Aug 24. Tumour Biol. 2014. PMID: 23975373

10

DNA repair genes XPC, XPG polymorphisms: relation to the risk of colorectal carcinoma and therapeutic outcome with Oxaliplatin-based adjuvant chemotherapy.

Liu D, Wu HZ, Zhang YN, Kang H, Sun MJ, Wang EH, Yang XL, Lian MQ, Yu ZJ, Zhao L, Olopade OI, Wei MJ. Liu D, et al. Mol Carcinog. 2012 Oct;51 Suppl 1:E83-93. doi: 10.1002/mc.21862. Epub 2011 Dec 27. Mol Carcinog. 2012. PMID: 22213216 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

77 results

Results by year